Immune responses to AAV capsid: Are mice not humans after all?

被引：45

作者：

Herzog, Roland W. ^{[1
]}

机构：

[1] Univ Florida, Div Mol & Cellular Therapy, Gainesville, FL 32610 USA

来源：

MOLECULAR THERAPY | 2007年 / 15卷 / 04期

关键词：

D O I：

10.1038/sj.mt.6300123

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：649 / 650

页数：2

共 16 条

[1] Determination of specific CD4 and CD8 T cell epitopes after AAV2-and AAV8-hF.IX gene therapy [J].

Chen, J ;

Wu, Q ;

Yang, P ;

Hsu, HC ;

Mountz, JD .

MOLECULAR THERAPY, 2006, 13 (02) :260-269

[2] Recombinant adeno-associated virus for muscle directed gene therapy [J].

Fisher, KJ ;

Jooss, K ;

Alston, J ;

Yang, YP ;

Haecker, SE ;

High, K ;

Pathak, R ;

Raper, SE ;

Wilson, JM .

NATURE MEDICINE, 1997, 3 (03) :306-312

[3] Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector [J].

Herzog, RW ;

Yang, EY ;

Couto, LB ;

Hagstrom, JN ;

Elwell, D ;

Fields, PA ;

Burton, M ;

Bellinger, DA ;

Read, MS ;

Brinkhous, KM ;

Podsakoff, GM ;

Nichols, TC ;

Kurtzman, GJ ;

High, KA .

NATURE MEDICINE, 1999, 5 (01) :56-63

[4] Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein [J].

Kessler, PD ;

Podsakoff, GM ;

Chen, XJ ;

McQuiston, SA ;

Colosi, PC ;

Matelis, LA ;

Kurtzman, GJ ;

Byrne, BJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :14082-14087

[5] Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes [J].

Li, Hua ;

Murphy, Samuel L. ;

Giles-Davis, Wynetta ;

Edmonson, Shyrie ;

Xiang, Zhiquan ;

Li, Yan ;

Lasaro, Marcio O. ;

High, Katherine A. ;

Ertl, Hildegund C. J. .

MOLECULAR THERAPY, 2007, 15 (04) :792-800

[6] AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B [J].

Manno, CS ;

Chew, AJ ;

Hutchison, S ;

Larson, PJ ;

Herzog, RW ;

Arruda, VP ;

Tai, SJ ;

Ragni, MV ;

Thompson, A ;

Ozelo, M ;

Couto, LB ;

Leonard, DGB ;

Johnson, FA ;

McClelland, A ;

Scallan, C ;

Skarsgard, E ;

Flake, AW ;

Kay, MA ;

High, KA ;

Glader, B .

BLOOD, 2003, 101 (08) :2963-2972

[7] Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response [J].

Manno, CS ;

Arruda, VR ;

Pierce, GF ;

Glader, B ;

Ragni, M ;

Rasko, J ;

Ozelo, MC ;

Hoots, K ;

Blatt, P ;

Konkle, B ;

Dake, M ;

Kaye, R ;

Razavi, M ;

Zajko, A ;

Zehnder, J ;

Nakai, H ;

Chew, A ;

Leonard, D ;

Wright, JF ;

Lessard, RR ;

Sommer, JM ;

Tigges, M ;

Sabatino, D ;

Luk, A ;

Jiang, HY ;

Mingozzi, F ;

Couto, L ;

Ertl, HC ;

High, KA ;

Kay, MA .

NATURE MEDICINE, 2006, 12 (03) :342-347

[8] T Cell Responses to AAV Vector Capsid in Normal Donors and Subjects Who Have Undergone Liver-Directed AAV-Mediated Gene Transfer [J].

Maus, Marcela V. ;

Mingozzi, Federico ;

Sabatino, Denise E. ;

Hui, Daniel ;

Ragni, Margaret V. ;

High, Katherine A. .

MOLECULAR THERAPY, 2006, 13 :S282-S282

[9] Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer [J].

Mingozzi, F ;

Liu, YL ;

Dobrzynski, E ;

Kaufhold, A ;

Liu, JH ;

Wang, YQ ;

Arruda, VR ;

High, KA ;

Herzog, RW .

JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (09) :1347-1356

[10]

Mingozzi F, 2006, BLOOD, V108, p138A

← 1 2 →